Taiho Pharmaceutical launches U.S. corporate venture capital arm
Taiho Pharmaceutical Co Ltd, of Tokyo, said May 10 that it has formed a U.S. corporate venture capital arm, Taiho Ventures. Taiho will invest in startups that focus on discovering and developing products that treat cancer. It will initially make investments from a pooled amount of $50 million.
10 May 2016•3 mins read
